Kardium has 6 close competitors: Attentive, Carbon Health, Certik.
Sector, valuation and status for each competitor.
company profile›
competitor›
competitor›
competitor›
competitor›
competitor›A private valuation and a public market cap share one column; each row names its basis and date.
KardiumAttentiveCarbon HealthCertikChainguardCollibraMedical device company developing systems for treating atrial fibrillation, the world's most common irregular heartbeat disorder.
Kardium competes with 6 companies here: Attentive, Carbon Health, Certik, Chainguard, Collibra, Controlled Thermal Resources.
Kardium was last valued at $1B (Aug 2026). That price was agreed in one transaction and holds until the next round. A listed competitor is repriced every trading session.
The routes section explains what is realistically available for a company at this stage.
No. Kardium is a private company; its shares do not trade on a public exchange.
The last valuation is $1B.
Perpetual markets for stocks, gold, indices and pre-IPO names — settled on-chain, no wallet-to-exchange transfers.
